Home/Filings/4/0001477449-24-000146
4//SEC Filing

Nanis Nikolaos P. 4

Accession 0001477449-24-000146

CIK 0001477449other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:05 PM ET

Size

19.7 KB

Accession

0001477449-24-000146

Insider Transaction Report

Form 4
Period: 2024-05-31
Nanis Nikolaos P.
Chief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-31+89472,390 total
  • Exercise/Conversion

    Common Stock

    2024-05-31+37070,991 total
  • Exercise/Conversion

    Common Stock

    2024-05-31+50571,496 total
  • Exercise/Conversion

    Common Stock

    2024-05-31+1,08573,475 total
  • Sale

    Common Stock

    2024-06-03$11.16/sh1,040$11,60372,435 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-315051,518 total
    Common Stock (505 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-311,0857,596 total
    Common Stock (1,085 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-05-313702,588 total
    Common Stock (370 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-318943,578 total
    Common Stock (894 underlying)
Footnotes (7)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F5]On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F6]On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F7]On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0002001935

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:05 PM ET
Size
19.7 KB